iiinova — where your digital self keeps evolving

Jill Feldman @jillfeldman4.bsky.social · 29/07/2025

Deadline is approaching! Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit Concepts welcome Deadline-August 8. Submit Abstract - ceconcepts.com/egfr-summit #NSCLC #ThoracicOnc #HOFellows #EGFRResisters #OncoAlert

030

Reposted by Jill Feldman

ASCO Palliative Oncology Community of Practice (PallOncCoP) @pallonccop.bsky.social · 23/11/2024

Welcome #pallonc #supponc folks to the official Blue Sky account for ASCO supported #PallOncCoP. Please follow for official Zoom meeting events, in-person conference meet ups like pic #ASCO24 and sharing the latest science in comfort and cure.

0169

Reposted by Jill Feldman

TingTing Zhang @tingtingzhang.bsky.social · 18/03/2025

I will co-chair with Prof Maryam Lustberg on June 26th AM "Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment." bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.

1155

Jill Feldman @jillfeldman4.bsky.social · 19/02/2025

My Guiding Compass in Advocacy: Speak up, but do it with respect. Challenge, but do it with understanding. And always push forward with purpose — Real change happens through conversation, not confrontation. I was 28 when my mom died, but her profound wisdom always guides me 💙

1305

Reposted by Jill Feldman

Lung Cancer Research Foundation @lcrf.org · 23/01/2025

Jill Feldman wrote a powerful article for @curetoday.bsky.social about the #LungCancerGeneticsStudy – a collaboration between nearly two dozen #LungCancer organizations and 23andme to uncover the genetic risks of lung cancer. Read it at: www.curetoday.com/view/the-pow... @jillfeldman4.bsky.social

curetoday.com

The Power of Unity: Why the Lung Cancer Genetics Study Matters

The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer

0146

Reposted by Jill Feldman

TingTing Zhang @tingtingzhang.bsky.social · 24/01/2025

ASCO has a palliative care community of practice in which a patient advocate pillar was organized with @jillfeldman4.bsky.social, Ameish, and I as members. I have served since September 2023 as the lead and will hand over the role later this year.

241

Reposted by Jill Feldman

TingTing Zhang @tingtingzhang.bsky.social · 24/01/2025

Please email pallonccop@gmail.com to be added to the listserv.

011

Jill Feldman @jillfeldman4.bsky.social · 16/01/2025

Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si #LCSM #EndStigmaNow

bit.ly

Helping Health Professionals Reduce Lung Cancer Stigma

Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.

082

Jill Feldman @jillfeldman4.bsky.social · 14/01/2025

THIS! Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer. Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏 #LCSM #SuppOnc bit.ly/4jiKwUz

bit.ly

COCOON study meets primary endpoint demonstrating statistically significant and clinically meaningful reduction in dermatologic reactions with easy-to-use prophylactic regimen for patients with EGFR-m...

0122

Jill Feldman @jillfeldman4.bsky.social · 24/12/2024

What a pleasure it was to meet Donghoon Shin! His passion and desire to learn from patient advocates was genuine and impressive. The future of #lungcancer research is bright😎 #LCSM #EGFR

091

Reposted by Jill Feldman

Advocates for Collaborative Education @advocatecollab.bsky.social · 16/12/2024

ICYMI "We must rethink how we define progress in oncology" #Oncosky #Cansky #Pallonc

052

Reposted by Jill Feldman

Laronica Conway @ronilynnwrites.bsky.social · 25/11/2024

“The most common cause of death from cancer is from lung cancer…yet just 16% of eligible people get screened for lung cancer, far lower than screening rates for colorectal or breast cancer. “ #medsky ktul.com/news/nation-...

ktul.com

More people surviving lung cancer, but work remains in screening and biomarker testing

The American Lung Association has released its annual "State of Lung Cancer" report.

1145

Jill Feldman @jillfeldman4.bsky.social · 25/11/2024

Innovation shouldn't come at the expense of patient-centered care! Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary. We must rethink how we define progress in #oncology #pallonc #LCSM bit.ly/3OJQuQB

bit.ly

The trade-off between accelerated cancer drug approvals and patient preferences

Cancer care stands at a critical juncture where the urgency of rapid drug approvals must be balanced against the need for enduring patient-centric benefits. Robin Forrest and colleagues1 conducted a d...

24620

Jill Feldman @jillfeldman4.bsky.social · 21/11/2024

It was an honor to co-author this article bit.ly/40WN9Vr It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face. It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care. #LCAM #LCSM

bit.ly

Lung cancer—a one-way ticket

The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disin

13213

Reposted by Jill Feldman

Dr Joseph McCollom DO @realbowtiedoc.bsky.social · 20/11/2024

Today's the day! Our last PallOncCoP meeting of 2024! Don't miss it. Not too late to DM📨 for Zoom 🔗. Always stay in the know by sending your prof email to pallonccop@gmail.com to be added to our listserv. @darcyburbage.bsky.social @tingtingzhang.bsky.social @jillfeldman4.bsky.social

251

Jill Feldman @jillfeldman4.bsky.social · 15/11/2024

The #lungcancer screening team at RushCancer Center has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening! #LCSM #LCAM #EarlyDetectionSavesLives

1454

Jill Feldman @jillfeldman4.bsky.social · 13/11/2024

📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/.... This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance. #LCSM #LCAM

03210

Reposted by Jill Feldman

Nathan Pennell MD, PhD, FASCO @n8pennell.bsky.social · 12/11/2024

Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3

brnw.ch

ASCO Election

0182

Reposted by Jill Feldman

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · 12/11/2024

"the new generation of cancer survivor [is] younger, less financially secure, and still having to navigate life after treatment, from dating to career, sex and child rearing" So glad that #AYAcsm #survonc #financialToxicity & #MBC issues are getting time on NPR www.npr.org/2024/11/11/n...

15421